Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey O'Callaghan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Ophthalmic Surgery, Lasers & Imaging Retina|December 15, 2021
Decreased CSF1R Signaling and the Accumulation of Reticular Pseudo-Drusen?Deirdre A Harford, Conor Delaney, Jeffrey O'Callaghan, et al.
Science Advances|April 19, 2023
Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucomaJeffrey O'Callaghan, Conor Delaney, Merissa O'Connor, et al.
Investigative Ophthalmology & Visual Science|January 14, 2026
Dynamic Inner Blood Retina Barrier Disruption in Retinitis PigmentosaKieva Byrne, Natalie Hudson, Jeffrey O'Callaghan, et al.
Molecular Therapy. Methods & Clinical Development|December 30, 2020
siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent modelPaul S Cassidy, Ruth A Kelly, Ester Reina-Torres, et al.
Investigative Ophthalmology & Visual Science|December 15, 2025
Automated Assessment of Retinal Vascular Integrity Across SpeciesJeffrey O'Callaghan, Natalie Hudson, Nicole Hanley, et al.
Science Translational Medicine|March 18, 2026
Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletesChris Greene, Declan Brennan, Sheida Mirloo, et al.
Nature Neuroscience|April 16, 2024
Author Correction: Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairmentChris Greene, Ruairi Connolly, Declan Brennan, et al.
Nature Neuroscience|February 22, 2024
Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairmentChris Greene, Ruairi Connolly, Declan Brennan, et al.
Cell Reports|November 11, 2025
Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNSErin Fahey, Lucia Celkova, Valentina Frezza, et al.
Human Molecular Genetics|February 4, 2017
Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucomaJeffrey O'Callaghan, Darragh E Crosbie, Paul S Cassidy, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Ophthalmic Surgery, Lasers & Imaging Retina|December 15, 2021
Decreased CSF1R Signaling and the Accumulation of Reticular Pseudo-Drusen?Deirdre A Harford, Conor Delaney, Jeffrey O'Callaghan, et al.
Science Advances|April 19, 2023
Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucomaJeffrey O'Callaghan, Conor Delaney, Merissa O'Connor, et al.
Investigative Ophthalmology & Visual Science|January 14, 2026
Dynamic Inner Blood Retina Barrier Disruption in Retinitis PigmentosaKieva Byrne, Natalie Hudson, Jeffrey O'Callaghan, et al.
Molecular Therapy. Methods & Clinical Development|December 30, 2020
siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent modelPaul S Cassidy, Ruth A Kelly, Ester Reina-Torres, et al.
Investigative Ophthalmology & Visual Science|December 15, 2025
Automated Assessment of Retinal Vascular Integrity Across SpeciesJeffrey O'Callaghan, Natalie Hudson, Nicole Hanley, et al.
Science Translational Medicine|March 18, 2026
Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletesChris Greene, Declan Brennan, Sheida Mirloo, et al.
Nature Neuroscience|April 16, 2024
Author Correction: Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairmentChris Greene, Ruairi Connolly, Declan Brennan, et al.
Nature Neuroscience|February 22, 2024
Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairmentChris Greene, Ruairi Connolly, Declan Brennan, et al.
Cell Reports|November 11, 2025
Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNSErin Fahey, Lucia Celkova, Valentina Frezza, et al.
Human Molecular Genetics|February 4, 2017
Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucomaJeffrey O'Callaghan, Darragh E Crosbie, Paul S Cassidy, et al.
Pageof 3